Author Archives: admin


Stem cell treatment used by Chris Johnson, hundreds of NFL …

New JetChris Johnson had stem cells from his bone marrow reinjected into his knee to augment Januarysurgery for a torn meniscus. The hope is that it wouldboost healingand perhaps rebuild cartilage. (AP)

Hes 28. He has five 1,000-yard NFL rushing seasons to his name, one 2,000-yarder and a burning desire to prove hes the same speedster hes always been. So when Chris Johnson visited orthopedic surgeon James Andrews in January to fix his ailing left knee, he liked the sound of two intriguing words: Stem cells.

The veteran running back tore the meniscus in that knee in Week 3 of the 2013 seasonhis last with the Titans before being cutbut never missed a game. The injury to the knees natural shock absorber also caused other damage in the joint, and Andrews presented an option that might augment what surgery alone could do. The plan: Take stem cells, the bodys universal building blocks, and deliver them directly to the construction site.

When I tore my meniscus and played the season out, through the wear and tear, I lost a lot of cartilage, says Johnson, who was signed by the Jets to bring explosiveness to their offense. When you put the stem cells in, it might be able to help rebuild that cartilage in your knee. Hopefully, it makes your knee better for even more years.

On the day of his surgery at the Andrews Institute in Gulf Breeze, Fla., Johnson had a small amount of his bone marrow60 milliliters, or the volume of a shot glasssiphoned out of the iliac crest of his pelvis with a long needle pushed through a tiny incision in his skin. Less than an hour later, at the end of the arthroscopic procedure to repair his meniscus, a concentrate of thousands of stem cells from the bone marrow was injected directly into Johnsons knee joint.

Instead of the usual four-to-six-week recovery time from the scope, Johnson stayed off the practice field for the rest of the offseason, giving the stem-cell treatment maximum time to work. At the least, stem cells are a powerful anti-inflammatory. But the hope is they may also play a role in boosting the healing of injured tissues, including stubborn ones like the meniscus, which lacks a robust blood supply, or cartilage, which has long been irreplaceable.

Stem cells are far from mainstreamNFL teams will often not pick up the bill, and the overseas market for treatments not approved in the U.S. makes the whole field seem somewhat taboo.

Johnson is one of hundredsyes, hundredsof NFL players who have invested in the promise of stem cells in the past few years. Peyton Manning reportedly tried a stem-cell treatment in Europe in 2011, his final year with the Colts, to fast-track his recovery from neck surgery. Giants cornerback Prince Amukamara had a slow-healing broken metatarsal treated with stem cells by a foot specialist in North Carolina after his teams Super Bowl XLVI run. One NFL linebacker paid $6,000 a pop for a 1-milliliter vial of donated placenta tissue containing stem cells to be injected into each of his beat-up knees this offseasonbut asked for his name not to be used in this story because he didnt tell his teams medical staff.

Such treatment is more common than you might realize among NFL players (hundreds of players across 32 teams averages to at least six players per team), but its also far from mainstream. Stem cells are still somewhat in the shadowsevidence of their usefulness in treating athletes injuries is so far largely anecdotal, NFL teams often will not pick up the bill for players, and the overseas market for treatments not approved in the U.S. makes the whole field seem somewhat taboo.

Theres a push to change that, though, and Andrews is an important figure at the forefront. His group is currently building a laboratory at its Florida facility specifically dedicated to biologicsthe term refers to substances that are produced in living systems such as humans, animals and microorganisms, rather than manufactured like drugsto be able to offer their star-studded clientele more of these treatments more effectively in the U.S. The agenda includes a research study with retired NFL players on how well stem cells work in treating arthritis of the knee; a trial of a Malaysian technique for regenerating cartilage by using stem cells from the blood after microfracture surgery; and exploring whether torn ACL tissue can be repurposed to help the new ligament graft heal more quickly.

More:
Stem cell treatment used by Chris Johnson, hundreds of NFL ...

The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies

Boston, MA (PRWEB) July 31, 2014

Bostons Adult Stem Cell Technology Center, LLC (ASCTC) finds itself flush with innovative adult stem cell biotechnologies. Currently the company holds seven recently issued patents and has three additional patent applications currently under examination by the U.S. Patent and Trademarks Office.

The patented inventions address two of the most vexing problems in adult stem cell biology research and regenerative medicine. Adult stem cells are difficult to identify; and they have been difficult to multiply to sufficient numbers to support regenerative medicine applications.

ASCTC has addressed the identity problem by developing patented biomarkers that are found exclusively on adult stem cells. The biomarkers are based on ASCTCs expertise in defining properties of adult stem cells that are not shared by any other normal cell types in the body. The patented biomarkers also identify some types of cancer stem cells. Therefore, they have applications in both stem cell medicine and cancer medicine.

ASCTCa success in developing procedures for producing adult stem cells in large numbers is due to the companys expertise in adult stem cell growth control. ASCTCs technology uses natural compounds found in the body to instruct adult stem cells to multiply in a controlled manner as during normal body growth.

The companys patented method for controlling adult stem cells to multiply without losing their stem cell properties has applications for many different types of adult stem cells. ASCTCs approved patents demonstrate the application of the method for production of human liver stem cells, hair follicle stem cells, and human pancreatic stem cells; but the technology has general application to adult stem cells found in many other types of organs and tissues.

In addition to the main focus on adult stem cell technologies, ASCTCs most recently issued patent applies its cell multiplication methods to produce induced pluripotent stem cells (iPSCs) without transferring exogenous genes. This gene-free single agent method should offer significant value to the many mushrooming companies that supply iPSCs and iPSC production reagents.

As a small start-up, ASCTC is employing a social media marketing strategy. In the past week, the company has launched patent licensing ads on LinkedIn, Vocus, and Facebook, as well increased its advertising references within its recently established Twitter presence.

It would be a shame for these technologies to lie dormant, just because our hands are full with other projects at the moment. James Sherley, director of ASCTC, relates that the companys two main business efforts require only a fraction of its available intellectual property. ASCTC is currently focused on bringing laboratory-scale production of human liver stem cells to manufacturing scales and developing a computer simulation assay for preclinical detection of drug candidates with intolerable toxicity due to adverse effects on adult stem cells.

Sherley adds, We already have a few companies that have expressed interest in licensing. But we could do a lot better at reaching others whose development efforts would benefit from ASCTCs unique technologies. Love to hear from ViaCyte!

See the article here:
The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies

Early stem cell transplant may cure "bubble boy" disease

"Bubble boy" David Vetter lived in a protective environment designed by NASA engineers. He died of complications after receiving a bone marrow transplant in 1984, at the age of 12. Baylor College of Medicine Photo Archives

Babies born with so-called "bubble boy" disease can often be cured with a stem cell transplant, regardless of the donor -- but early treatment is critical, a new study finds.

Severe combined immunodeficiency (SCID), as the condition is medically known, actually refers to a group of rare genetic disorders that all but eliminate the immune system. That leaves children at high risk of severe infections.

The term "bubble boy" became popular after a Texas boy with SCID lived in a plastic bubble to ward off infections. The boy, David Vetter, died in 1984 at the age of 12, after an unsuccessful bone marrow transplant -- an attempt to give him a functioning immune system.

15 Photos

Immune disorder forced David Vetter to live in bubble - but breakthroughs from his story now enable similar kids to live free

In the best-case scenario, a child would get stem cells -- the blood-forming cells within bone marrow -- from a sibling who is a perfect match for certain immune-system genes.

But that's not always an option, partly because kids with SCID are often their parents' first child, said Dr. John Cunningham, director of hematopoietic stem cell transplantation at the University of Chicago Comer Children's Hospital. He was not involved in the study.

In those cases, doctors typically turn to a parent -- who is usually a "half" match, but whose stem cells can be purified to improve the odds of success. Sometimes, stem cells from an unrelated, genetically matched donor can be used.

The good news: Regardless of the donor, children with SCID can frequently be cured, according to the new findings. But early detection and treatment is vital.

Read the original:
Early stem cell transplant may cure "bubble boy" disease

Extracted fat put forward as cure for wobbly knees

Mary Ann Benitez

Thursday, July 31, 2014

Health Innovative Technology chief executive Matthew Fan Chun-yin said his company is banking on the fat graft's potential as a drug in future and acquired ProStemCell last year to expand its bio- bank storage and research capabilities.

The government plans to issue new rules and regulations governing stem cell laboratories, he said.

During a tour of the laboratories of HIT ProStemCell in Kowloon Bay, Fan said scientists discovered stem cells from the extracted fat stimulate the repair of the knee cartilage and relieves pain for osteoarthritic patients.

He said it was unfortunate that liposuction has been tarnished by the death of a dance teacher and studio owner Josephine Lee Ka-ying, 32, who fell comatose and died after a four-hour liposuction treatment at the Regrowth Hair Transplant Centre in Tsim Sha Tsui on June 27 this year.

"You should not do any liposuction in a non-qualified day surgery center," said Fan, a former dietician.

He said ProStemCell, which HIT acquired last year, built a "clean-room" laboratory four years ago which meets the US Food and Drug Administration's standards.

The classification is the same required of companies for drug manufacturing and for hospital operating theaters which do open-heart surgery.

ProStemCell built the laboratory because the administration put out guidelines in 2009 requiring such stringent laboratory guidelines.

Read more:
Extracted fat put forward as cure for wobbly knees

Regenerative Medicine Solutions – Home – Stem Cell …

Regenerative Medicine Solutions (RMS) is a leading global provider of Stem Cell Treatments, Platelet-Rich Plasma (PRP), Natural Growth Factors and other innovative regenerative medical technologies,for the treatment of an array of debilitating medical conditions. Through our individualized, patient-centric approach, we are providing the highest quality of care and consistent positive outcomes. By applying todays best practices to the growing field of regenerative medicine RMS is changing lives.

RMS is results-driven, having positively improved the quality of life for hundreds of patients. At RMS, the safety of every patient is our top priority. All of the procedures performed at RMSs state-of-the-art clinics are in compliance with the highest standards of safety. The quality of care provided by our team of medical experts is unsurpassed in the industry.

RMS is sensitive to the distressing nature of our patients conditions, therefore our focus is to provide them with a superior level of personalized care and to make them comfortable throughout the entire treatment process. Supported by ground breaking developments in clinical science and stem cell therapy, RMS is welcoming the future of medicine through the application of our innovative regenerative technologies.

100%

of procedures are outpatient

100%

of procedures are minimally invasive

100+

years of combined physician experience

500+

Originally posted here:
Regenerative Medicine Solutions - Home - Stem Cell ...

Stem Cells to Renew the Health and Lives of People – Aishwarya Rai Bachchan in Chennai – Video


Stem Cells to Renew the Health and Lives of People - Aishwarya Rai Bachchan in Chennai
Stem Cells to Renew the Health and Lives of People - Aishwarya Rai Bachchan in Chennai - RedPix 24x7 #AishwaryaRai #AishwaryaRaiBachchan #StemCells #LifeCell LifeCell is India #39;s first and...

By: Red Pix 24x7

See original here:
Stem Cells to Renew the Health and Lives of People - Aishwarya Rai Bachchan in Chennai - Video

Chris Johnson Opens Up About Stem Cell Treatment with the MMQB

Chris Johnson was once the most dynamic running back in the NFL. Now, following his move from the Tennessee Titans to the New York Jets, he's hoping cutting-edge medical treatment can help him return to those previous levels of production and extend his career.

Jenny Vrentas of The MMQB reports Johnson underwent stem-cell treatment as part of his recovery from an injury to his left knee. Dr. James Andrews, who's well known for his work with athletes across the sports spectrum, handled the procedure.

The three-time Pro Bowl ball-carrier explained he suffered meniscus damage in Week 3 last season, but he decided to fight through the injury. While he ended up playing in all 16 games, he certainly didn't look like the player Titans fans once knew.

At 28, he's entering a period when most running backs begin to fade due to the cumulative damage after years of absorbing hits and general fatigue. Johnson hopes the treatment can help him avoid that drop-off.

"When I tore my meniscus and played the season out, through the wear and tear, I lost a lot of cartilage," he told Vrentas. "When you put the stem cells in, it might be able to help rebuild that cartilage in your knee. Hopefully, it makes your knee better for even more years."

Vrentas also spoke with Andrews, who states there are still question marks surrounding the benefits of the treatments. Still, he's trying to help the research pick up steam stateside so players won't have to keep going to Europe or elsewhere, making it unclear exactly what they're being provided with.

Ultimately, his hope is combining the stem-cell treatments with normal recovery methods like surgery can further accelerate how quickly athletes get back in the game.

"Instead of taking a year, a year and a half in order to get well, maybe we can cut that down in half," he said. "We have an old saying: 'You can't bargain with Mother Nature.' The biologics, the stem-cell therapy, is the revelation that may change that."

If Johnson can showcase the form that allowed him to rush for more than 2,000 yards en route to being named the AP Offensive Player of the Year in 2009, perhaps Andrews' wish will begin to take shape.

The returns are promising so far. Manish Mehta of the New York Daily News pegged Johnson as one of the standout players early in Jets training camp:

Read this article:
Chris Johnson Opens Up About Stem Cell Treatment with the MMQB

Lung Institutes Medical Director Celebrates 55th Anniversary in Medical Practice

Tampa, FL (PRWEB) July 29, 2014

This month marks a milestone for the Lung Institutes Medical Director, Dr. Burton Feinerman, as he celebrates his 55th anniversary in the medical field. Practicing medicine for over half a century, Dr. Feinerman has distinguished himself as a world-renowned physician in the field of regenerative medicine with the development of innovative stem cell treatments for lung diseases like chronic obstructive pulmonary disease (COPD).

Dr. Feinermans medical career has been punctuated by many firsts. In the 1950s and 1960s, Dr. Feinerman was the owner of Opa-Locka General Hospital, the only private hospital accepting African Americans in Miami, Florida. He also set up the first Pediatric Emergency Rooms in South Florida at Parkway Hospital and Miami General Hospital.

The Lung Institutes medical director was also involved with the first successful allogeneic (genetically dissimilar) bone marrow transplant performed on a 10-month-old child with severe combined/immunodeficiency, known as bubble baby. This patient, who was given a very poor prognosis of life expectancy, is now 36-years-old and a high school teacher. In 1998, Dr. Feinerman set up the first medical service website site, Webmedicalservices.com, to directly answer patient questions, which later became a public company.

It was during his time in Hawaii as the first physician to offer cosmetic dermatology and anti-aging medicine that Dr. Feinerman initially became interested in stem cells. Over subsequent years, he developed stem cell patents for a variety of disorders including Amyotrophic Lateral Sclerosis (ALS), Parkinsons, Alzheimers, multiple sclerosis, autism, cerebral palsy, COPD, pulmonary fibrosis, diabetes types 1 and 2, end-stage kidney disease and brain damage in children and adults. He also developed patents for gene therapies to treat such conditions as Tay-Sachs, Sandhoff disease, Huntingtons disease and metachromatic leukodystrophy.

Dr. Feinermans stem cell quest continues at Regenerative Medicine Solutions and Lung Institute, with his current research aimed at conquering neurological and chronic lung diseases as well as diseases causing blindness such as age-related macular degeneration, retinitis pigmentosa, and stargardts disease.

I am humbled at the acknowledgement of my role as a catalyst for change in medicine, confessed Dr. Feinerman who was honored last year as Lifetime Achievement Award finalist for the Tampa Bay Business Journals Healthcare Heroes. When I reflect back on my medical career, I only see my patients.

About the Lung Institute At the Lung Institute, we are changing the lives of hundreds of people across the nation through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive stem cell therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at (855) 469-5864.

See the rest here:
Lung Institutes Medical Director Celebrates 55th Anniversary in Medical Practice